
Number of publications published per year by Gordon, Stuart C.. (Source : PubMed)

Distribution of publications types for Gordon, Stuart C.. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Risk for Renal Cell Carcinoma in Chronic Hepatitis C Infection.
Cancer Epidemiol. Biomarkers Prev.
2010

Disclosure of the genetic risk of Alzheimer's disease.
N. Engl. J. Med.
2010;362;2



Merimepodib, pegylated interferon, and ribavirin in genotype 1 chronic hepatitis C pegylated interferon and ribavirin nonresponders.
Hepatology
2009;50;6
Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage.
Hepatology
2009

Prolonged intrahepatic cholestasis and renal failure secondary to anabolic androgenic steroid-enriched dietary supplements.
J. Clin. Gastroenterol.
2009;43;7


Differences in hepatic phenotype between hemochromatosis patients with HFE C282Y homozygosity and other HFE genotypes.
J. Clin. Gastroenterol.
2009;43;6
A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma.
Hepatology international
2009



Telaprevir with peginterferon and ribavirin for chronic HCV genotype 1 infection.
N. Engl. J. Med.
2009;360;18

Treatment of HBV/HCV coinfection: releasing the enemy within.
Gastroenterology
2009;136;2
Bioelectrical impedance analysis for the evaluation of hepatic fibrosis in patients with chronic hepatitis C infection.
Dig. Dis. Sci.
2008;53;7
[ See timeline ] [ See all publications ]
means that Gordon, Stuart C. has 30 papers cited a least 30 times - methodology
Duke Clinical Research Institute and Duke University, Durham, NC 27715, USA.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.